Patient-reported outcomes from the phase III IMpassion130 trial of atezolizumab plus nab-paclitaxel in metastatic triple-negative breast cancer - Adams, Sylvia; Dieras, V.; Barrios, C. H.; Winer, E. P.; Schneeweiss, Andreas; Iwata, H.; Loi, S.; Patel, S.; Henschel, V.; Chui, S. Y.; Rugo, H. S.; Emens, L. A.; et al. (Annals of oncology, 2020)
Gesehen am 15.07.2020